Distinct MHC gene expression patterns during progression of melanoma
- 27 October 2009
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 49 (2), 144-154
- https://doi.org/10.1002/gcc.20728
Abstract
Abnormal expression of major histocompatibility complex (MHC) molecules in melanoma has been reported previously. However, the MHC molecule expression patterns in different growth phases of melanoma and the underlying mechanisms are not well understood. Here, we demonstrate that in vertical growth phase (VGP) melanomas, MHC genes are subject to increased rates of DNA copy number gains, accompanied by increased expression, in comparison to normal melanocytes. In contrast, MHC expression in metastatic melanomas drastically decreased compared to VGP melanomas, despite still prevalent DNA copy number gains. Subsequent investigations found that the master transactivator of MHC genes, CIITA, was also significantly downregulated in metastatic melanomas when compared to VGP melanomas. This could be one of the mechanisms accounting for the discrepancy between DNA copy number and expression level in metastatic melanomas, a potentially separate mechanism of gene regulation. These results infer a dynamic role of MHC function in melanoma progression. We propose potential mechanisms for the overexpression of MHC molecules in earlier stages of melanoma as well as for its downregulation in metastatic melanomas.Keywords
This publication has 47 references indexed in Scilit:
- Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.2003
- MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma.2003
- Genomic amplification and oncogenic properties of the KCNK9 potassium channel geneCancer Cell, 2003
- Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.2003
- Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridizationCytometry, 2001
- Constitutive Expression of MHC Class II Genes in Melanoma Cell Lines Results from the Transcription of Class II Transactivator Abnormally Initiated from Its B Cell-Specific PromoterThe Journal of Immunology, 2001
- Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.2001
- A listing of human tumor antigens recognized by T cellsCancer Immunology, Immunotherapy, 2001
- Multiple Genetic Alterations Cause Frequent and Heterogeneous Human Histocompatibility Leukocyte Antigen Class I Loss in Cervical CancerThe Journal of Experimental Medicine, 2000
- Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional SignificanceAdvances in Immunology, 1999